MIA:
- WHO ATC First Level (Anatomical main group) ID: J ANTIINFECTIVES FOR SYSTEMIC USE
- WHO ATC Second Level (Therapeutic subgroup) ID: J05 ANTIVIRALS FOR SYSTEMIC USE
- WHO ATC Third Level (Pharmacological subgroup) ID: J05A DIRECT ACTING ANTIVIRALS
- WHO ATC Fourth Level (Chemical subgroup) ID: J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors
- WHO ATC Fifth Level (Chemical substance) ID: J05AB14 Valganciclovir
- Chemical Name: Valganciclovir', 'DB01004 name: Ganciclovir
- Chemical Smi: OCC(OCn1cnc2c1[nH]c(N)nc2=O)COC(=O)[C@H](C(C)C)N', 'DB01004 smi: OCC(OCn1cnc2c1[nH]c(N)nc2=O)CO
- WHO ICD Mapped Level : B25.9 B25.9 Name: Cytomegaloviral disease, unspecified
- WHO ICD Fourth Level ID: B25.9 B25.9 Name: Cytomegaloviral disease, unspecified
- WHO ICD Third Level ID: B25 B25 Name: Cytomegaloviral disease
- WHO ICD Second Level ID: B25-B34 B25-B34 Name: Other viral diseases
- WHO ICD First Level ID: I I Name: Certain infectious and parasitic diseases
|
|